Qiming Leads $20M Round In Chinese Start-Up Connect Biopharmaceuticals
January 25, 2017 — 15:00 CST
This Data Is Locked!
This area is available only to Subscribers.
Qiming Venture Capital has led a US$20 million series A round in Connect Biopharmaceuticals Ltd., a clinical-stage company developing immune modulators for autoimmune diseases and... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals